Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsNicole Mayer-Hamblett, Jessica Carey, Katherine Odem‐Davis et al.|The Lancet Respiratory Medicine|2022Cited by 128
Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic FibrosisAlex H. Gifford, Jonathan B. Zuckerman, Alexandra C. Hinton et al.|CHEST Journal|2023Cited by 5
C‐Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary ExacerbationsJonathan B. Zuckerman, Alex H. Gifford, Alexandra C. Hinton et al.|Pediatric Pulmonology|2025Cited by 1